ABOLERIS PHARMA ANNOUNCES €27.3 MILLION IN SERIES A FINANCING TO ADVANCE ITS NOVEL TREATMENT PARADIGM FOR AUTOIMMUNE AND INFLAMMATORY DISEASES

AbolerIS Pharma (“AbolerIS”), a biopharmaceutical company developing an entirely novel approach to the treatment of chronic autoimmune and inflammatory diseases, today announced a €27.3 million Series A financing led by Caixa Capital Risc and co-led by Sound Bioventures and existing investor Newton Biocapital with participation from SFPI-FPIM, WE, Sambrinvest, Investsud Tech, and Relyens Innovation Santé/Turenne […]

Continue Reading

ON SEPTEMBER 20, 2023, JOIN US FOR #WORLDGODAY!

On the 5th World Gynecologic Oncology Day, patient advocates around the globe will unite to raise awareness about the importance of testing for gynecologic cancers and their risk factors. World GO Day is a unique opportunity to educate people worldwide about the importance of sharing information about symptoms, treatment, prevention and, especially, testing. GO for […]

Continue Reading

PATIENTS DEMAND PRESCRIPTION APPS FROM NHS FOR MENTAL HEALTH AND OBESITY TREATMENT – NEW RESEARCH

New research from tech consulting and engineering firm Zühlke reveals that there is huge unmet demand for prescription apps from the NHS across the whole UK population – particularly for prevention of high-volume illnesses where the NHS is struggling to cope with demand, such as depression, anxiety, obesity & diabetes, and cancer. Its research, published […]

Continue Reading

WITHINGS’ NEW GENERATION CONSUMER WRISTWATCH SCANWATCH 2, CAN NOW TRACK CORE BODY TEMPERATURE 24/7

greenteg’s CALERA® technology provides temperature tracking in new generation hybrid, health-monitoring wristwatch. greenteg, the Swiss-based innovator in sensing technology, has collaborated with WITHINGS on their new generation hybrid watch ScanWatch 2, which includes an additional health matrix to track body temperature. With the integration of greenteg’s CALERA® technology, this latest hybrid watch offers a revolutionary […]

Continue Reading

CALL FOR APPLICATIONS: WOMEN AND YOUTH IN 24 AFRICAN COUNTRIES FOR 6-MONTH DIGITAL SKILLS TRAINING PROGRAMME BY UNITAR, GOVERNMENT, PEOPLE OF JAPAN

The United Nations Institute for Training and Research (UNITAR), in partnership with the Government and people of Japan, invite women and youth in 24 African countries to apply to the training programme “Developing Essential Digital Skills for Women and Youth in Africa: Enhancing Employment Opportunities and Livelihood Development in the Digital Economy”. The six-month programme […]

Continue Reading

EUDoctor.org Introduces Mobile and Web Telemedicine Platform

EUDoctor.org Introduces Mobile and Web Telemedicine Platform, Empowering EU Patients with Prescription, Sick Note, and Certificate Services.   EUDoctor.org Introduces Mobile and Web Telemedicine Platform, Empowering EU Patients with Prescription, Sick Note, and Certificate Services, Led by CEO Eva Simunović…   EUDoctor.org, a leading healthcare technology company, is delighted to announce the launch of its […]

Continue Reading

FLYMEDI CELEBRATES EIGHT YEARS OF FACILITATING QUALITY MEDICAL TOURISM IN TURKEY

Flymedi, a premier medical tourism company, celebrates eight successful years of connecting patients worldwide with world-class medical treatments in Turkey. Founded in 2015, Flymedi has garnered international acclaim for its comprehensive, reliable, and affordable medical travel services.   Medical tourism is a thriving global sector, attracting millions of patients internationally each year. Flymedi, through its […]

Continue Reading

WORLD’S OLDEST MAN TURNS 114

Juan Vicente Pérez Mora Reaches Extraordinary Achievement   [PRESSWIRE] San José de Bolívar, Táchira, Venezuela – Juan Vicente Pérez Mora, the oldest living man in the world and the oldest living person in Venezuela, has reached 114 years of age. Sr. Pérez Mora has been the world’s oldest living man since the death of Spain’s […]

Continue Reading

CEBINA Announces Positive Results of a Phase 2 Clinical Study with COVID-19 patients and Azelastine Nasal Spray Published in a Peer-Reviewed Scientific Journal

CEBINA GmbH, Central European Biotech Incubator and Accelerator, today announces the publication of the positive results of a Phase 2 clinical study that tested azelastine nasal spray as a new approach for reducing viral load in the nose of SARS-CoV-2 positive patients in the peer-reviewed journal Scientific Reports (1).   Vaccines have been a useful […]

Continue Reading